<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Yuping Gong</submitter><species>Homo Sapiens</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0016422000</full_dataset_link><submitter_email>gong2025@wchscu.edu.cn</submitter_email><submitter_affiliation>West China Hospital</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Proteomic profiling of bone marrow aspirate (BMA) samples collected pre-VD-CAG induction and post-induction VD-CAG-treated non-M3 AML</name><description>Proteomic profiling was performed by Novogene (Beijing, China), using data-independent acquisition (DIA) proteomics on paired bone marrow aspirate samples from 5 non-M3 AML patients before and after VD-CAG treatment. All patients achieved composite complete response (CRc) after 1 cycle of VD-CAG induction. Protein extraction, quantification, enzymatic digestion with trypsin (allowing up to 2 missed cleavage sites), desalting, and fractionation were conducted following standard protocols to ensure data quality at each step. Peptides were separated using nano-LC on a Vanquish Neo system and analyzed on an Orbitrap Astral high-resolution mass spectrometer, which features a quadrupole for precursor ion selection, an Orbitrap analyzer for high-dynamic-range HRAM spectra, and an Astral analyzer for high-sensitivity, up to 200 Hz HRAM spectral acquisition.</description><dates><publication>Mon Mar 30 00:00:00 BST 2026</publication></dates><accession>PXD076348</accession><cross_references><TAXONOMY>9606</TAXONOMY></cross_references></HashMap>